2023-10-11
Hong Kong
October 11, 2023
Great Bay Bio (GBB), a pioneering AI-enabled biotechnology company, and a renowned multinational corporation (MNC) in the life science industry have officially launched a strategic cooperation centered around AI-driven cell culture media development. Based on the powerful development capabilities of GBB's AI-enabled culture database platform (AlfaMedX) and the value and management of MNC's global supply chain, this project will provide more high-quality media products and solutions for numerous biopharmaceutical companies worldwide, helping to improve the resilience of the global culture media industry chain.

Platform FAQ | AlfaCell Frequently Asked Questions (Business Edition)
2026-11-12

Event Recap | Great Bay Bio Successfully Concludes Its 2nd Technical Seminar on Site-Specific Integration for Cell Line Development
2026-11-09

Platform FAQ | AlfaCell Frequently Asked Questions (Case Studies Edition)
2026-11-04